The "Infusion Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's ...

Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only ...

MedAware, an AI platform improving patient safety, demonstrates the shift from rule-based systems to data-driven, ...

The enforcement action came after the healthcare facility failed to settle significant debts owed to its workforce and ...

Commentary: Social media users correctly spotted my misdiagnosis. Here are two diabetes tech wearables everyone should know ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

A new treatment is changing the lives of those with early onset Type 1 Diabetes. A new drug approved by the Food and Drug ...

GSA Capital Partners LLP lowered its holdings in Iradimed Corporation (NASDAQ:IRMD – Free Report) by 21.3% in the 3rd quarter ...

Modeled after the state’s $6 billion cancer research fund, the dementia fund — a legislative priority for Lt. Gov. Dan ...

The global Implantable Drug Eluting Devices Market is poised for substantial growth, projected to expand at a compound annual growth rate (CAGR) of 6.0% from 2022 to 2029. The market, valued at ...

Of the 50 startups on Foresight Canada’s 2024 list of the most investable cleantech startups, half are B.C. companies, six of ...

With more than 325,000 pumps installed worldwide, the Plum A+™ general purpose infusion system remains the proven choice for caregivers and clinicians alike. The scalable platform can be ...